Sure thing. That one was the best I've found so far. What I am really looking for is the RVR/EVR data. I know it must be out there somewhere. This link mentions it but gives no details. Wish I could find one of those charts one finds with most studies where all of the arms are side by side. BTW, nitazoxanide in Mexico is being offered at $2.66 per tab / Canada at $3.50 / here it runs more than $16 ea. I don't hink it is likely that your insurance co. will fund this "off label" treatment. jerry
http://www.hivandhepatitis.com/2007icr/aasld/docs/111307_d.html
Not so clear huh? 4wks NTZ, then 4wks NTZ+SOC and UND. Will that be considered RVR and bring the possibility of shortened treatment time? (my Hughes Sat. connection is running sooooo slowwwww tonite!) jm
Hey, They did a 12 week lead w/ NTZ, then 36 wks Soc+NTZ. For the US trials they are talking 4wk NTZ first. Will that be a 40wk total or 48 (4ntz+44ntz+soc) or 4ntz+ 48ntz+soc. With all this RVR could mean shortened INF exposure I wonder if 4wk ntz+4wkntz+soc would = RVR and shorter treatment time??Man! It's enough to give ya a headache! jerry
The presentation was titled " Interim data from a randomized controlled trial of Nitazoxanide-Peginterferon-Ribavirin, Nitazoxanide-Peginterferon and Peginteferon-Ribavirin in the treatment of patients with chronic hepatitis C Genotype 4." Abstract #178. at the annual AASLD conference in Boston.
Those patients stayed on the NTZ for the full duration of the treatment ( 48 weeks)